Roche dumps its cancer drug R&D pact with Wilex

John Carroll

is bowing out of a two-year-old collaboration with a subsidiary of a struggling .

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS